9th Antifibrotic Drug Development Summit

Media Partnership 

between Fibrosis and 9th Antifibrotic Drug Development Summit

The 9th Antifibrotic Drug Development Summit stands as the premier industry-driven forum bringing together drug developers across IPF, MASH, systemic sclerosis, and kidney, cardiac, and gastrointestinal fibrosis to address common challenges from early discovery through Phase 2.

Download the event guide to learn more about the 25+ insightful sessions delivered by expert speakers, networking opportunities with 80+ attendees from companies such as Pfizer, Novartis, and GSK, and discover how to align your program with pharma’s $1B+ licensing appetite.

Don't miss your chance to join us this November 17-19 in Boston, MA, USA! Use the code 'sciepublishfibrosis10' for an exclusive 10% discount!